Xiaodong Guan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Topics

Network Analysis

Antimicrobial Resistance

Childhood Cancer

Top Venues

Antibiotics (Basel, Switzerland)

Nature reviews. Clinical oncology

Pharmacoepidemiology and drug safety

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tiansheng Wang, Dongze Ji, Til Stürmer, Sherine Ismail, Shujie Dong, Peng Shen, Hongbo Lin, Luwen Shi, Xiaodong Guan, Yang Xu
The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Mengyuan Fu, Zhiwen Gong, Yuezhen Zhu, Can Li, Huangqianyu Li, Lu-Wen Shi, Xiaodong Guan
Disparity in Guideline-Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017-2019. Pharmacoepidemiology and drug safety 33 (8) (2024)
Haishaerjiang Wushouer, Kexin Du, Junxuan Yu, Wanmeng Zhang, Lin Hu, Weihsin Ko, Mengyuan Fu, Bo Zheng, Luwen Shi, Xiaodong Guan
Outpatient Antibiotic Prescribing Patterns in Children among Primary Healthcare Institutions in China: A Nationwide Retrospective Study, 2017-2019. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Haishaerjiang Wushouer, Kexin Du, Junxuan Yu, Wanmeng Zhang, Lin Hu, Weihsin Ko, Mengyuan Fu, Bo Zheng, Luwen Shi, Xiaodong Guan
Outpatient Antibiotic Prescribing Patterns in Children among Primary Healthcare Institutions in China: A Nationwide Retrospective Study, 2017-2019. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Haishaerjiang Wushouer, Weihsin Ko, Kexin Du, Wanmeng Zhang, Lin Hu, Junxuan Yu, Kairui Zhang, Luwen Shi, Xiaodong Guan
Exploring Facilitators and Barriers to Delayed Antibiotic Prescribing in Rural Northwest China: A Qualitative Study Using the Theoretical Domains Framework and Behavior Change Wheel. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Yichen Zhang, Dingyi Chen, Siyuan Cheng, Zhizhou Liang, Lu Yang, Qian Li, Lin Bai, Huangqianyu Li, Wei Liu, Luwen Shi, Xiaodong Guan
Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016-2021: An observational study. PLoS medicine 20 (12) (2023)
Yue Zhou, Huseyin Naci, Dingyi Chen, Lin Bai, Lu-Wen Shi, Xiaodong Guan, Anita Katharina Wagner
Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021. BMJ global health 8 (9) (2023)
Xiaoyan Nie, Ruilin Wang, Guangkai Liang, Xinyi Zhang, Ningjia Tang, Yuchun Cai, Congxiao Han, Yuxuan Zhao, Tong Jia, Fang Zhang, Sheng Han, Xiaodong Guan, Lu-Wen Shi, Christine Y Lu
The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study. International journal of health policy and management 12 (2023)
Haishaerjiang Wushouer, Kexin Du, Shicai Chen, Huangqianyu Li, Wanmeng Zhang, Yaoyao Yang, Lin Hu, Yue Zhou, Hui Sun, Bo Zheng, Xiaodong Guan, Luwen Shi
Evaluation of prescription review and feedback policy on rational antibiotic use in primary healthcare settings in Beijing, China: a qualitative study using the Theoretical Domains Framework and the behaviour change wheel. JAC-antimicrobial resistance 5 (6) (2023)
Yichen Zhang, Anita K Wagner, Xiaodong Guan
Newly approved cancer drugs in China - innovation and clinical benefit. Nature reviews. Clinical oncology (2023)
Zixuan He, Xianqin Huang, Dingyi Chen, Guoan Wang, Yuezhen Zhu, Huangqianyu Li, Sheng Han, Luwen Shi, Xiaodong Guan
Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review. BMJ global health 8 (11) (2023)
Yichen Zhang, Anita K Wagner, Xiaodong Guan
Newly approved cancer drugs in China - innovation and clinical benefit. Nature reviews. Clinical oncology 20 (3) (2023)
Yichen Zhang, Anita K Wagner, Xiaodong Guan
Newly approved cancer drugs in China - innovation and clinical benefit. Nature reviews. Clinical oncology 20 (3) (2023)
Huajie Hu, Ruilin Wang, Huangqianyu Li, Sheng Han, Peng Shen, Hongbo Lin, Xiaodong Guan, Luwen Shi
Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China. Health policy and planning (2023)
Haishaerjiang Wushouer, Weihsin Ko, Kexin Du, Wanmeng Zhang, Lin Hu, Junxuan Yu, Kairui Zhang, Luwen Shi, Xiaodong Guan
Exploring Facilitators and Barriers to Delayed Antibiotic Prescribing in Rural Northwest China: A Qualitative Study Using the Theoretical Domains Framework and Behavior Change Wheel. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Haishaerjiang Wushouer, Lin Hu, Yue Zhou, Yaoyao Yang, Kexin Du, Yanping Deng, Qing Yan, Xiaoqiang Yang, Zhidong Chen, Bo Zheng, Xiaodong Guan, Luwen Shi
Trends of Fixed-Dose Combination Antibiotic Consumption in Hospitals in China: Analysis of Data from the Center for Antibacterial Surveillance, 2013-2019. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Yuxuan Zhao, Xinyi Zhang, Congxiao Han, Yuchun Cai, Sicong Li, Xiaowen Hu, Caiying Wu, Xiaodong Guan, Christine Lu, Xiaoyan Nie
Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis. Journal of personalized medicine 12 (7) (2022)
Haishaerjiang Wushouer, Lu-Wen Shi, Xiaodong Guan, Yi Min Cui
China starts to pay for pharmaceutical services. Journal of clinical pharmacy and therapeutics 47 (7) (2022)
Xiaowen Hu, Tong Jia, Xinyi Zhang, Caiying Wu, Yuqing Zhang, Jing Chen, Xiaodong Guan, Luwen Shi, Christine Y Lu, Xiaoyan Nie
Clinical Pharmacists' Involvement in Pharmacogenomics Testing and Related Services in China. Journal of personalized medicine 12 (8) (2022)
Aichen Yu, Guilin Wei, Fanghui Chen, Zining Wang, Mengyuan Fu, Guoying Wang, Haishaerjiang Wushouer, Xixi Li, Xiaodong Guan, Luwen Shi
Study protocol for the evaluation of pharmacist-participated medication reconciliation at county hospitals in China: a multicentre, open-label, assessor-blinded, non-randomised, controlled study. BMJ open 12 (3) (2022)
Yichen Zhang, Yuxuan Wei, Huangqianyu Li, Yixuan Chen, Yiran Guo, Sheng Han, Luwen Shi, Xiaodong Guan
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. PharmacoEconomics 40 (7) (2022)
Cong Huang, Carolina Oi Lam Ung, Haishaerjiang Wushouer, Lin Bai, Tao Huang, Xinyi Li, Xiaodong Guan, Luwen Shi
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines? Health research policy and systems 20 (1) (2022)
Tao Huang, Anita Katharina Wagner, Lin Bai, Cong Huang, Xiaodong Guan, Luwen Shi
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending. Cancer communications (London, England) 41 (4) (2021)
Mengyuan Fu, Haishaerjiang Wushouer, Lin Hu, Nan Li, Xiaodong Guan, Luwen Shi, Dennis Ross-Degnan
Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China. NPJ primary care respiratory medicine 31 (1) (2021)
Huajie Hu, Yichen Zhang, Dawei Zhu, Xiaodong Guan, Luwen Shi
Physician patient-sharing relationships and healthcare costs and utilization in China: social network analysis based on health insurance data. Postgraduate medicine 133 (7) (2021)
Cong Huang, Carolina Oi Lam Ung, Haishaerjiang Wushouer, Lin Bai, Xinyi Li, Xiaodong Guan, Lu-Wen Shi
Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis. International journal of health policy and management (2021)
Mengyuan Fu, Haishaerjiang Wushouer, Xiaoyan Nie, Nan Li, Xinyan Zhang, Fang Wang, Xiaodong Guan, Luwen Shi
Protocol of a tailored educational intervention for general practitioners on potentially inappropriate medications among older patients at community healthcare institutions in Beijing, China: a cluster-randomised controlled trial. BMJ open 11 (7) (2021)
Yue Zhou, Haishaerjiang Wushouer, Daniel Vuillermin, Xiaodong Guan, Luwen Shi
Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis. The European journal of health economics : HEPAC : health economics in prevention and care 22 (3) (2021)
Lin Bai, Cong Huang, Ziyue Xu, Tao Huang, Xiaodong Guan, Luwen Shi
Differences of healthcare utilization and cost between cancer inpatients with and without depression: Based on national health insurance database. Psycho-oncology 30 (6) (2021)
Yichen Zhang, Anita Katharina Wagner, Haoxin Du, Taisen Han, Sumit Gupta, Avram E Denburg, A Lindsay Frazier, Xiaodong Guan, Lu-Wen Shi
Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States. International journal of cancer 150 (3) (2021)
Zhigang Guo, Lin Bai, Zhenhuan Luo, Mengyuan Fu, Liguang Zheng, Xiaodong Guan, Luwen Shi
Factors Associated with Free Medicine Use in Patients with Hypertension and Diabetes: A 4-Year Longitudinal Study on Full Coverage Policy for Essential Medicines in Taizhou, China. International journal of environmental research and public health 18 (22) (2021)
Mengyuan Fu, Haishaerjiang Wushouer, Xiaoyan Nie, Luwen Shi, Xiaodong Guan, Dennis Ross-Degnan
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China. Pharmacoepidemiology and drug safety 29 (8) (2020)
Jingyuan Zhang, Carolina Oi Lam Ung, Xiaodong Guan, Luwen Shi
Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015. BMC pregnancy and childbirth 19 (1) (2019)